0001181431-13-004491.txt : 20130124
0001181431-13-004491.hdr.sgml : 20130124
20130124123146
ACCESSION NUMBER: 0001181431-13-004491
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130123
FILED AS OF DATE: 20130124
DATE AS OF CHANGE: 20130124
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHAPLIN DAVID
CENTRAL INDEX KEY: 0001167232
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21990
FILM NUMBER: 13544798
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OXIGENE INC
CENTRAL INDEX KEY: 0000908259
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 133679168
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 701 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-635-7000
MAIL ADDRESS:
STREET 1: 701 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
rrd366939.xml
CHAPLIN - FORM 4
X0306
4
2013-01-23
0
0000908259
OXIGENE INC
OXGN
0001167232
CHAPLIN DAVID
C/O OXIGENE, INC.
701 GATEWAY BLVD., SUITE 210
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (Right to Buy)
4.36
2013-01-23
4
A
0
6260
0
A
2013-01-23
2019-01-23
Common Stock
6260
6260
D
Dr. Chaplin was awarded options to purchase shares of OXiGENE, Inc. common stock, $0.01 par value per share (the "Stock Options") pursuant to the OXiGENE, Inc. Amended and Restated Non-Employee Director Compensation Policy in connection with his appointment to the Board of Directors of the Issuer and as partial payment for Board of Directors services to be provided during the first six months of 2013.
The Stock Options were fully vested as of the grant date.
/s/ Megan N. Gates, Attorney-in-fact
2013-01-24